Jumonji domain containing-3 (JMJD3)  inhibition attenuates IL-1β-induced chondrocytes damage in vitro and protects osteoarthritis cartilage in vivo

ConclusionsThis study elucidates the important role of JMJD3 in cartilage degeneration in OA, and our results indicate that JDJM3 may become a novel therapeutic target in OA therapy.
Source: Inflammation Research - Category: Research Source Type: research